Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SLNO stock hub

Soleno Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SLNOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.8B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

SLNO

In the news

Latest news · SLNO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.6

P25 12.3P50 18.4P75 33.1

Trailing P/E30

P25 14.9P50 23.2P75 38.5

ROE26.4

P25 -105.6P50 -46.5P75 -3.1

ROIC13.4

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SLNO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

226

Groups with data

Currency

USD

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001484565
Company name	Soleno Therapeutics, Inc.
Country	United States
Country code	US
Cusip	834203200
Employees	182
Employees Change	90%
Employees Change Percent	97.83
Enterprise value	$2.3B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2014-11-13
Isin	US8342033094
Last refreshed	2026-05-10
Market cap	$2.8B
Market cap category	Mid-Cap
Price	$52.95
Price currency	USD
Rev Per Employee	1,565,978.02x
Sector	Healthcare
Sic	2834
Symbol	SLNO
Website	https://soleno.life

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.47%
EV Earnings	23.9x
EV Sales Forward	4.79x
EV/EBIT	25.53x
EV/EBITDA	24.97x
EV/FCF	48.9x
EV/Sales	8.02x
FCF yield	1.69%
Forward P/E	11.59x
P/B ratio	5.52x
P/E ratio	29.97x
P/S ratio	9.68x
PS Forward	5.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	31.4%
EBITDA Margin	32.11%
FCF margin	16.39%
Gross margin	98.63%
Gross Profit	$281.1M
Net Income	$95.6M
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Pretax Margin	34.94%
Profit Margin	33.7%
Profit Per Employee	$525,418
Profitable Years	1
ROA	12.07
Roa5y	-31.4
ROCE	16.26
ROE	26.38
Roe5y	-79.29
ROIC	13.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-4.84%
Cagr1y	-29.1%
Cagr3y	138.92%
Cagr5y	26.04%
EPS Growth Quarters	3
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.62
Assets	$608.4M
Cash	$255.6M
Current Assets	$355.8M
Current Liabilities	$61.4M
Debt	$54.3M
Debt EBITDA	$0.59
Debt Equity	$0.11
Debt FCF	$1.16
Equity	$495.8M
Interest Coverage	16.55
Liabilities	$112.6M
Long Term Assets	$252.6M
Long Term Liabilities	$51.2M
Net Cash	$474.7M
Net Cash By Market Cap	$17.2
Net Cash Growth	70.62%
Net Debt EBITDA	$-5.19
Net Debt Equity	$-0.96
Net Debt FCF	$-10.16
Tangible Book Value	$491.4M
Tangible Book Value Per Share	$9.5
WACC	-7.6

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.62
Net Working Capital	$13.9M
Quick ratio	5.22
Working Capital	$268.3M
Working Capital Turnover	$1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-30.39%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-39.14%
1Y total return	-29.08%
200-day SMA	53.38
3Y total return	1,264.69%
50-day SMA	44.08
50-day SMA vs 200-day SMA	50under200
5Y total return	218.02%
All Time High	742.5
All Time High Change	-92.87%
All Time High Date	2015-03-04
All Time Low	0.85
All Time Low Change	6,129.41%
All Time Low Date	2022-12-15
ATR	0.63
Beta	-2.22
Beta1y	1.8
Beta2y	0.92
Ch YTD	14.36
High	52.96
High52	90.32
High52 Date	2025-07-09
High52ch	-41.38%
Low	52.93
Low52	29.43
Low52 Date	2026-03-27
Low52ch	79.92%
Ma50ch	20.13%
Premarket Change Percent	-0.09
Premarket Price	$52.9
Premarket Volume	178
Price vs 200-day SMA	-0.81%
RSI	77.55
RSI Monthly	52.06
RSI Weekly	55.76
Sharpe ratio	-0.21x
Sortino ratio	-0.23
Total Return	-30.39%
Tr YTD	14.36
Tr1m	1.15%
Tr1w	0.15%
Tr3m	27.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	4
Analyst Price Target Top	$73
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$0.69
Earnings Revenue Estimate	94,364,584x
Operating Income	$89.5M
Operating margin	31.4
Price target	$74.14
Price Target Change	$40.02
Price Target Change Top	$37.87

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	48,554,984%
Float Percent	93.16%
Shares Insiders	1.28%
Shares Institutions	94.14%
Shares Out	52,120,147
Shares Qo Q	-1.08%
Shares Yo Y	30.39%
Short Float	11.95%
Short Ratio	0.93
Short Shares	11.13

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-498,000
Average Volume	2,382,179.8x
Bv Per Share	9.59
CAPEX	$-108,000
Ch10y	-39.14
Ch1m	1.15
Ch1w	0.15
Ch1y	-29.08
Ch3m	27.5
Ch3y	1,264.7
Ch5y	218
Ch6m	11.01
Change	0%
Change From Open	0
Close	52.95
Days Gap	0
Depreciation Amortization	2,017,000
Dollar Volume	64,064,893.4
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$89.5M
EBITDA	$91.5M
EPS	$1.77
F Score	4
FCF	$46.7M
FCF EV Yield	2.04x
FCF Per Share	$0.9
Financing CF	132,900,000
Fiscal Year End	December
Founded	1,999
Graham Number	19.52302
Graham Upside	-63.13
Income Tax	$3.5M
Investing CF	-186,735,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-02-25
Last Report Date	2025-12-31
Last Split Date	2022-08-26
Last Split Type	Reverse
Last10k Filing Date	2026-02-25
Ma150	47.85
Ma150ch	10.67%
Ma20	52.77
Ma20ch	0.33%
Net CF	51,695,000
Next Earnings Date	2026-05-22
Open	52.95
Optionable	Yes
P FCF Ratio	59.06
P OCF Ratio	26.15
Position In Range	66.67
Post Close	52.95
Postmarket Change Percent	0.02
Postmarket Price	$52.96
Ppne	2,376,000
Pre Close	52.95
Price Date	2026-05-08
Price EBITDA	$30.16
Ptbv Ratio	5.62
Relative Volume	0.51x
Revenue	285,008,000x
SBC By Revenue	16.57x
Share Based Comp	47,223,000
Tax By Revenue	1.24x
Tax Rate	3.55%
Tr6m	11.01%
Us State	California
Volume	1,209,913
Z Score	17.41

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SLNO pay a dividend?

Capital-return profile for this ticker.

Performance

SLNO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SLNO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+94.1%

Float: +93.2% of shares outstanding

Insider ownership

+1.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SLNO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

77.5

Above 70: short-term overbought

Price vs 200-day MA

-0.8%

50/200-day relationship not available

Beta (5Y)

-2.22

Less volatile than the market

Sharpe ratio

-0.21

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SLNO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SLNO stock rating?

Soleno Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SLNO analysis?

The full report lives at /stocks/SLNO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SLNO?

The latest report frames SLNO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SLNO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.